Tuesday, November 8, 2022

New drug can successfully treat patients typically resistant to high blood pressure treatment

A new drug called Baxdrostat has been shown to significantly reduce high blood pressure (hypertension) in patients who may not respond to current treatments for the condition, according to results from a phase II trial.

from Top Health News -- ScienceDaily https://ift.tt/PjoipzZ
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

A protein older than blood circulation could transform cancer immunotherapy

A protein that evolved long before the human circulatory system may help unlock stronger cancer treatments. When C3 is produced inside tumor...